AT2 Receptors Attenuate AT1 Receptor-Induced Phospholipase D Activation in Vascular Smooth Muscle Cells
Authors:
- Bradley T. AndresenBABradley T. Andresen
- Guillermo G. RomeroGRGuillermo G. Romero
- Edwin K. JacksonEJEdwin K. Jackson
Open Access
- 1 April 2004
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 309 (1) , 425-431
Abstract
Previous studies indicate that angiotensin (AT)1 receptor-induced activation of phospholipase D (PLD) may importantly contribute to vascular hypertrophy, injury, and contraction. However, the role of AT2 receptors in regulating AT1 receptor-induced PLD activation is unknown. In this study, we identified angiotensin II receptors on cultured preglomerular vascular smooth muscle cells (PGSMCs) from spontaneously hypertensive rats (SHR) and Wistar Kyoto rats (WKY) by reverse transcription-polymerase chain reaction (RT-PCR) and binding assays and examined their functional effects on angiotensin II-mediated PLD activity. Both RT-PCR and binding indicated that cultured SHR and WKY PGSMCs expressed AT1 and AT2 receptors, and the combined total of AT1 and AT2 receptors was similar between the strains. However, the number of AT1 and AT2 receptors differed between SHR and WKY PGSMCs in so much as the ratio of AT1 to AT2 receptors was approximately 1 to 1 and 3 to 1 in WKY and SHR PGSMCs, respectively. As previously reported, angiotensin II more potently activated PLD in SHR PGSMCs (SHR EC50 = 4 nM; WKY EC50 = 47 nM). Addition of an AT2 receptor-specific antagonist or agonist shifted the angiotensin II-mediated PLD concentration-response curve of WKY PGSMCs in a manner consistent with AT2 receptors producing an inhibitory signal. In contrast, in SHR little change was observed. Our findings indicate that the ratio of AT1 to AT2 receptors in vascular smooth muscle cells may be a determinant of the net effects of angiotensin II on PLD activity due to AT2-dependent inhibition of AT1-mediated PLD activity. Furthermore, cultured WKY PGSMCs provide an excellent model system to study endogenous AT2 receptor signal transduction.Keywords
This publication has 42 references indexed in Scilit:
- α2-Adrenoceptors Potentiate Angiotensin II- and Vasopressin-Induced Renal Vasoconstriction in Spontaneously Hypertensive RatsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Angiotensin Type 2 Receptor-Mediated Hypotension in Angiotensin Type-1 Receptor-Blocked RatsHypertension, 2001
- Overexpression of β1 and β2Adrenergic Receptors in Rat Atrial MyocytesJournal of Biological Chemistry, 2001
- Analysis of Gα protein recognition profiles of angiotensin II receptors using chimeric Gα proteinsMolecular and Cellular Endocrinology, 2000
- Nitric oxide: a physiological mediator of the type 2 (AT2) angiotensin receptorActa Physiologica Scandinavica, 2000
- Increased Vasoconstrictor Response of the Mouse Lacking Angiotensin II Type 2 ReceptorBiochemical and Biophysical Research Communications, 1999
- Inhibition of Cell Proliferation and Activation of Protein Tyrosine Phosphatase Mediated by Angiotensin II Type 2 (AT2) Receptor in R3T3 CellsBiochemical and Biophysical Research Communications, 1996
- Characterization and Hemodynamic Implications of Renal Vascular Angiotensin II Receptors in SHRJournal of Molecular and Cellular Cardiology, 1996
- The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.Journal of Clinical Investigation, 1995
- Identification of angiotensin II receptor subtypesBiochemical and Biophysical Research Communications, 1989